Raloxifene, a SERM targets PD-L1: an in-silico study.
Chopra C, Yodun T, Singh H, Singh B, Singh SK, Goutam U.
Chopra C, et al. Among authors: singh h, singh sk, singh b.
Am J Transl Res. 2023 Aug 15;15(8):5206-5215. eCollection 2023.
Am J Transl Res. 2023.
PMID: 37692949
Free PMC article.